PubMed Health⌕ Search

Biomedical subjects

Zhilan Peng

Publications and source records attributed to Zhilan Peng.

14 recordsLinked to original sources

[Primary study on the method for separating mature sperms from human testicular tissue].

This study was aimed to explore a simple and applicable method of separating mature sperms from human testicular tissue for intracytoplasmic sperm injection and embryo transfer. The suspension of human testicular tissue was cultured in 10% human serum albumin and human tubule fluid with different concentrations (0 u/ml; 50 u/ml; 100 u/ml; 150 u/ml; 200 u/ml) of hyaluronidase for 24 h, and then the Percoll gradient centrifugation was processed to separate the sperms; meanwhile the sperms were counted and graded according to their motility. The difference in quality and quantity among the groups and the difference between the groups and the zero-hour culturing group were detected. It was shown that the four hyaluronidase-treated groups contained large quantity and high quality of sperms as compared with the two contrast groups (P<0.01). The groups in the solution of 50 u/ml, 100 u/ml and 150 u/ml concentrations of hyaluronidase had almost the same amount of sperms that displayed higher motility as compared against the sperms in the group treated with 200 u/ml concentration of hyaluronidase (P<0.01). There was no difference between the two contrast groups (P>0.05), or among the groups treated with 50 u/ml, 100 u/ml, and 150 u/ml of hyaluronidase concentration (P>0.05). This method of adopting hyaluronidase with Percoll gradient centrifugation in the process for separating mature sperms from human testicular tissue is applicable. It can increase the quantity and quality of sperms separated from testicular tissue suspensions when adequate concentrations of hyaluronidase is used.

Adult↗

[Application of short tandem repeat DNA in model of human-mouse cord blood transplantation].

OBJECTIVE: To evaluate the significance of applying short tandem repeat DNA in the model of human-mouse cord blood transplantation. METHODS: The techniques of STR-PCR and colony forming cell culture were used to examine the engrafting and influence of hematopoietic growth factor on process in the mice after transplantation of human cord blood (CB). RESULTS: 1. Human DNA expression was detected in the mice that had received tail-vein injection of human CB (1-5 x 10(7) MNC per mouse) but it was not detected in the mice that have received intraperitoneal injection of human CB. 2. Human CB transplanted in SCID mice could reconstitute the hematopoietic function of the mice; the expression level of human cell was not related with the use of hematopoietic growth factor. CONCLUSION: STR-PCR analysis provide a simple and accurate indication of engraftment in the model of human-mouse cord blood transplantation.

Animals↗

[Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].

OBJECTIVE: To assess the efficacy of microdetermination in the ATP-bioluminescence assay (ATP-CVA) of ovarian cancer chemosensitivity testing in vitro. METHODS: A micromethod ATP-CVA was employed in determining the chemosensitivity of 35 specimens of fresh ovarian cancer cells using Victor 2 Multilabel Counter. RESULTS: 1. By use of Victor 2 Multilabel Counter to determine ATP, in a range of 10(-9)-10(-5) mol/ml, a linear relationship was remarkable between the log ATP and the log luminescence. The equation was Y = 0.892X + 10.257, the correlation coefficient r was 0.998, P < 0.01. 2. The coefficient of variation obtained from ATP-CVA was 7.3%. 3. The sensitivity of the test was 92.0%, the specificity 70.0%, and the total predictive accuracy of ATP-CVA 87.1%. CONCLUSION: With the use of Victor 2 Multilabel Counter, ATP-CVA is fast, cost-effective, and easy to perform with only small error.

Adenosine Triphosphate↗

[An experimental research in the inhibiting effect of bFGF-MAb on the growth of ovarian cancer cells and transplanted tumor].

OBJECTIVE: To investigate whether the monoclonal antibody of basic fibroblast growth factor (bFGF-MAb) inhibits the proliferation, invasion and angiogenesis of ovarian cancer. METHODS: 1. Human ovarian cancer cells SKOV3 were planted in 24-well dishes, to which was added bFGF-MAb at different concentrations, and crystal violet staining was performed daily for 8 days, then cell numbers were counted by OD490 determination. 2. SKOV3 were transplanted intraperitoneally to BALB/c nude mice. One week later, bFGF-MAb was injected intraperitoneally twice a week, and the survival time of nude mice, the number and weight of the metastatic tumors on the mensentery were observed or measured. 3. Intratumoral microvessel density(MVD) was measured by immunohistochemical staining for CD31. RESULTS: 1. bFGF-MAb inhibited the proliferation of SKOV3 in the concentration-dependent manner (P < 0.05). 2. The average survival time of nude mice in bFGF-MAb group increased by 10 days over that of control. 3. The average number and weight of metastatic tumors on mensentery in bFGF-MAb group constituted 70.6% and 69.2% of those in control group, respectively. 4. The MVD in bFGF-MAb group accounted for 62.8% of the MVD in control group. CONCLUSION: bFGF-MAb can inhibit the proliferation and angiogenesis of ovarian cancer markedly, so it promises to have application in the biological treatment of ovarian cancer.

Animals↗

[Gene therapy for ovarian cancer by adenovirus-mediated transduction of cytosine deaminase gene in vitro].

OBJECTIVE: To study the value of adenovirus mediated expression of the Escherichia coli cytosine deaminase (CD) gene with 5-fluorocytosine (5-FC) in the gene therapy of ovarian cancer cells. METHODS: Ovarian cancer cells were transduced CD gene by adenovirus vector and exposed to varying concentration of 5-FC. After 5 days of incubation, MTT assays were performed to measure the cell viability. RESULTS: It was shown that tumor cells transduced with CD gene had a high sensitivity to 5-FC. Mixed cellular assay revealed that CD-postive cells had a neighbor cell killing effect on CD-negative cells when exposed to 5-FC. 20% CD positive cells killed more than 80% mixed cells. CONCLUSION: CD/5-FC gene therapy approach is an effective anti-tumor strategy in the treatment of ovarian cancer.

Adenoviridae↗

[Expression and correlation of C-met and estrogen receptor in endometrial carcinomas].

OBJECTIVE: To investigate the expression and correlation of C-met and Estrogen receptor (ER) in endometrial carcinomas. METHODS: We examined 55 samples of endometrial carcinomas using specific polyclonal endometrial carcinomas. METHODS: antibody and monoclonal antibody correspondent to the human C-met and ER respectively. The histochemical score was estimated according to the formula H = (i + 1) x pi, with a criterion of equal or more than 70 as considered to be positive in expression. RESULTS: The expression of C-met was correlated with both histological grade and clinical stage of endometrial carcinomas. The H scores of carcinomas in grade 3 was higher than in grade 1 and grade 2, while higher H scores were found in carcinomas in stage III and II compared to stage I (P < 0.05). The higher of the grade and stage were, the weaker the ER were expressed in endometrial carcinomas (P < 0.05). There was an inverse correlation between the expression of ER and C-met (r = -0.5842 P < 0.05). CONCLUSIONS: The expression of C-met and ER might be a useful predictor for the prognosis of endometrial carcinomas and an indicator to evaluate the effectiveness of the hormone intervention.

Adenocarcinoma↗

[Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].

OBJECTIVE: To evaluate the anticancer effects of cytosine deaminase (CD) gene/5-fluorocytosine (5-FC) to human ovarian papillary serous cystadenocarcinoma in nude mice. METHODS: Replication-deficient adenovirus containing CD gene was used to transfect human embryonal kidney cell line 293, and the adenovirus's concentration was up to 1 x 10(10) pfu (plaque forming unit)/ml after purification. Ten female BULB/C nude mice were implanted subcutaneously with approximate 0.08 g tissue of ovarian papillary serous cystadenocarcinoma from the parental generation, and they were divided into test group and control group. While the tumors grew with diameter of approximate 3mm, test group received intratumoral injections of adenovirus-CD at 1 x 10(9) pfu in a 100 microl volume on day 1, 3, 5. These animals were administered 5-FC at doses of 400 mg/kg twice daily by intraperitoneal injection from day 1 to day 7. Normal saline was used in control group with the same volume and by the same methods. Tumor volumes were measured in following days. RESULTS: (1) Compared with control group, the growth of tumors in test group was significantly suppressed. Twenty days after the therapies, the tumor volumes in test group and control group were (91 +/- 68) mm(3) and (238 +/- 122) mm(3) respectively, there was significant difference. This difference lasted for approximately 30 days (P = 0.045 - 0.019). (2) The mean time of tumor volume doubling in test group and control group were (8.1 +/- 0.7) days and (6.4 +/- 0.7) days, respectively (P < 0.05). CONCLUSIONS: This research has shown the significant effects of CD gene/5-FC on human ovarian cancer in nude mice model. The results may be the important basis of clinical trials. They suggest that this toxic gene/prodrug therapy system may play an important role in ovarian cancer therapy in the future.

Adenoviridae↗

Tissue array technique for p53 expression in human ovarian neoplasms.

OBJECTIVE: To investigate the expression of p53 in human ovarian neoplasms by tissue array technique. METHODS: The expression of p53 protein in various ovarian tissues was studied by tissue array and immunohistochemistry. RESULTS: The expression rate of p53 was 33% in ovarian cancers. There were no expressions in normal ovarian tissues, benign ovarian neoplasms and borderline ovarian neoplasms (P < 0.005). p53 expression was not associated with age of patients and grade of differentiation (P > 0.05) while p53 expression was associated with tissue types (P < 0.05). CONCLUSION: The expression rates of p53 in ovarian cancers were obviously increased.

Female↗

[A clinicopathological study on minimal deviation adenocarcinoma of uterine cervix].

OBJECTIVE: Minimal deviation adenocarcinoma (MDA) is frequently underdiagnosed in pathology tests due to its benign histopathological features. Therefore, its clinical and pathological characters need to be further analyzed and to establish useful immunohistochemical markers to improve the accuracy of pathological diagnosis. METHODS: Clinical pathology data were of 13 MDA cases collected and analyzed in the First and Second Hospitals attached to the University, the pathological characters were compared with matched benign hyperplastic and atypical hyperplastic controls of the glandular epithelial cells to find histochemical and immunohistochemical indices valuable for the pathological diagnosis. 8 of these 13 cases were followed and their conditions were discussed. RESULTS: The main clinical symptoms were watery leucorrhagia, enlargement of the cervix with erosion and hardening. Thickened ligaments were also detected in some cases. The pathological findings included hyperplasia and mild abnormality of the glands, invasion effects into the stroma could be observed in some glands and abortive glands with desmoplastic changes, or edema and inflammatory infiltration around the glands were also observed. The invasion presented in the deep part of the cervix as well, some were found near larger blood vessels or in the small vessels. Compared with benign glands, the immunohistochemical indices of most MDA glands were demonstrated as cancer embryo antigen (CEA) + + +, Ki-67 +--+ + +, P53 +--+ + +, AB/PAS +/+ +, and focal defect on the basement membrane. CONCLUSIONS: Once any of the diagnostic characters summarized as above was determined, the probability of MDA should be seriously considered, at least atypical hyperplasia in cervical glands must be diagnosed, and follow-up on the patients and histological biopsy of deep tissues (> 5 mm) of the cervix will be necessary to determine the inclusion/exclusion of MDA. Obviously, a correct pathological diagnosis is extremely important for the patient to receive proper treatment in time and thereby improve her quality of life.

Adenocarcinoma↗

[The role of progesterone in the regulation of gene expression of insulin-like growth factor-I receptor in human decidual stromal cells of early pregnancy in vitro].

OBJECTIVE: To assess the effect of progesterone on the gene expression of insulin-like growth factor-I receptor (IGF-I R) in human decidual stromal cells of early pregnancy in vitro. METHODS: Semiquantitative reverse transcriptase polymerase chain reaction, using beta-ACTIN as internal standard, was applied to determine the levels of IGF-I R mRNA in human decidual stromal cells of early pregnancy in vitro after cultured with different concentrations of progesterone for 72 hours or cultured with 0.1 mumol/L of progesterone for different periods of time. RESULTS: The expression of IGF-I R mRNA was significantly positive in human decidual stromal cells of early pregnancy in vitro. The levels of IGF-I R mRNA were down-regulated by progesterone, and showed significant negative-correlation with the concentration of progesterone (r = -0.680, P < 0.001). The levels of IGF-I R mRNA showed no significant correlation with time when the final concentration of progesterone was 0.1 mumol/L (r = 0.005, P > 0.05). CONCLUSION: Progesterone may play an important role in the regulation of proliferation and decidualization of stromal cells by down-regulating the expression of IGF-I R mRNA in human decidual stromal cells of early pregnancy, which is important for the maintenance of early pregnancy.

Adult↗

[Gene expression of insulin-like growth factors in human villous trophoblast cells of early pregnancy in vitro].

OBJECTIVE: To investigate the gene expression of insulin-like growth factors(IGFs) in human villous trophoblast cells of early pregnancy in vitro and their action. METHODS: Semiquantitative reverse transcriptase polymerase chain reaction(RT-PCR), with beta-ACTIN as internal standard, was applied to determine the expression of IGFs messenger RNA in human villous trophoblast cells of early pregnancy in vitro. RESULTS: The expression of IGF-II mRNA, IGF-I R mRNA and IGFBP-3 mRNA was detectable in human villous trophoblast cells of early pregnancy in vitro. CONCLUSION: IGFs appear to play important regulation roles in early invasion, proliferation and differentiation of cytotrophoblast, and in the formation of placenta and the development of embryo via autocrine and/or paracrine way.

Adult↗

[Comparison between apoptosis cells count and ATP-bioluminescence assay in ovarian cancer chemosensitivity testing in vitro].

OBJECTIVE: This study was aimed to evaluate the potentiality for the use of apoptosis cells count as a chemosensitivity testing in vitro for ovarian cancer. METHODS: An end-labelling assay was used to determine the apoptosis cells of 4 specimens of fresh ovarian cancer cells and the results were compared with that of ATP assay. RESULTS: It was found that chemotherapy can induce apoptosis, and the same chemotherapeutic agent can induce different apoptosis cells for different cancers. CONCLUSION: The observed agreement between apoptosis cells count and ATP assay was 0.75. The above data demonstrate that apoptosis cells count can be used as a chemosensitivity testing for ovarian cancer, and a combination of these two methods may improve the clinical effects of chemotherapeutic agents.

Antineoplastic Agents↗

[Effects of wild-type p53 gene transfection on the growth and cisplatin sensitivity of cervical cancer cell line HeLa].

OBJECTIVE: To investigate the effects of human wild-type p53 gene transfection on the growth and chemosensitivity of human cervical carcinoma. METHODS: Recombinant eukaryotic expression vector pCB6.p53 containing human wild-type p53 cDNA was introduced by lipofectamine transfection regent into HeLa cell line. The expression of p53 was detected by immunohistochemistry. Cell proliferation was measured by methyl thiazolyl tetrazolium after the treatment of cisplatin. RESULTS: Expression of p53 was detected by immunohistochemistry. The growth rate of p53-transfected HeLa decreased. Wild-type p53-positive HeLa was more sensitive to cisplatin, compared with the control cell lines. CONCLUSION: The exogenous wild-type p53 expression not only induced great suppression of cell growth but also increased chemosensitivity of human cervical carcinoma.

Antineoplastic Agents↗